Banking Recap

PMGC Holdings Inc. Prices Equity Offering for $100.0M

PMGC Holdings Inc., a healthcare sector company trading under the ticker ELAB, is conducting an at-the-market equity issuance with a disclosed aggregate offering price of $100,000,000. An at-the-market offering, or ATM, is an equity capital markets transaction that allows an issuer to sell shares into the public market opportunistically over time, typically at prevailing market prices, rather than in a single block transaction. This transaction type provides issuers with flexibility regarding the timing and volume of share sales while giving them access to capital up to a specified aggregate amount.

Apr 24, 2025·SEC EDGAR·announced·At-The-Market Issuance

Deal value

The transaction was announced on April 24, 2025, based on documentation filed with the SEC on EDGAR. The specific SEC filing form type is not identified in the available sourcing materials. The deal is currently in announced status, though no expected closing date or timeline for share sales under the agreement has been disclosed.

On the financial advisory side, Univest Securities, LLC is serving as the sales agent for the offering under the at-the-market issuance sales agreement. Univest is identified as the lead and sole financial advisor on this transaction. The sourcing materials confirm that under the terms of the agreement, PMGC Holdings may issue and sell from time to time shares of its common stock, par value $0.0001 per share, through Univest Securities in its capacity as sales agent or through any sub-agent or other designee that Univest may appoint to assist in the offering.

On the legal advisory side, Sichenzia Ross Ference Carmel LLP is providing counsel to PMGC Holdings. The specific scope of their legal work is not detailed beyond their provision of an opinion related to the offering.

The transaction structure provides for the issuance of common stock only. The shares are identified as having par value of $0.0001 per share. The maximum aggregate offering price across all shares that may be sold is $100,000,000. The sales agreement permits the sales agent to act through sub-agents or other designees, providing operational flexibility in the execution of share sales. Beyond these structural terms, no additional information regarding the mechanics of the offering, pricing parameters, or conditions to sales has been disclosed.

Several material details regarding this offering remain undisclosed. No timeline or expected closing date for the at-the-market agreement has been provided. The specific number of shares to be issued or the anticipated pricing range has not been disclosed. The terms of Univest's compensation as sales agent are not specified in the available materials. Finally, while Sichenzia Ross Ference Carmel LLP is identified as providing legal counsel, the full scope of their engagement and any other legal advisors assisting either party have not been detailed.